These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis]. Achiron A; Miron S Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin treatment in multiple sclerosis. Gadoth N; Melamed E; Miller A; Steiner I; Abramsky O Neurology; 1999 Jan; 52(1):214-5. PubMed ID: 9921886 [No Abstract] [Full Text] [Related]
5. Intravenous immunoglobulin treatment in multiple sclerosis. Francis G Neurology; 1999 Jan; 52(1):214. PubMed ID: 9921885 [No Abstract] [Full Text] [Related]
6. [Immunoglobulin G is effective in multiple sclerosis]. Favrbo K Ugeskr Laeger; 2005 Jan; 167(1):81; author reply 81. PubMed ID: 15675176 [No Abstract] [Full Text] [Related]
8. [Drug treatment in multiple sclerosis--1995]. Achiron A Harefuah; 1995 Dec; 129(12):579-83. PubMed ID: 8682363 [No Abstract] [Full Text] [Related]
9. [Treatment of multiple sclerosis: current opinion]. Yamamura T No To Shinkei; 2001 Aug; 53(8):707-13. PubMed ID: 11577411 [No Abstract] [Full Text] [Related]
10. [Immunoglobulins in multiple sclerosis]. Cendrowski W Postepy Hig Med Dosw; 1973; 27(4):499-505. PubMed ID: 4732719 [No Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504 [TBL] [Abstract][Full Text] [Related]
12. Long-term treatment of multiple sclerosis with IgG immunotherapy. Schuller E; Lambin P; Deloche G Pathol Biol (Paris); 1996 Oct; 44(8):710-5. PubMed ID: 8977930 [TBL] [Abstract][Full Text] [Related]
14. Roles of immunoglobulins and B cells in multiple sclerosis: from pathogenesis to treatment. Antel J; Bar-Or A J Neuroimmunol; 2006 Nov; 180(1-2):3-8. PubMed ID: 16934338 [TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis. Ford H; Nicholas R Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466 [No Abstract] [Full Text] [Related]
16. [Recent progress in treatment for multiple sclerosis]. Kira J Rinsho Shinkeigaku; 2000 Dec; 40(12):1261-3. PubMed ID: 11464473 [TBL] [Abstract][Full Text] [Related]